Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. | Director | Common Stock | 812K | $23.6M | $29.03 | Sep 30, 2024 | Indirect |
Denali Therapeutics Inc. | Director | Common Stock | 29.1K | $845K | $29.03 | Sep 30, 2024 | Direct |
Guardant Health, Inc. | Director | Common Stock | 9.91K | $219K | $22.12 | Oct 31, 2024 | Direct |
PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 53.5K | $111K | $2.08 | Jun 13, 2024 | Direct |
Guardant Health, Inc. | Director | Restricted Stock Units | 3.09K | $68.3K | $22.12 | Oct 31, 2024 | Direct |
Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 51.8K | Jun 16, 2023 | Direct | ||
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17.9K | May 31, 2024 | Direct | ||
Guardant Health, Inc. | Director | Stock Option (Right to Buy) | 10.7K | Jun 12, 2024 | Direct |